Genetics of osteoarthritis.


Journal

Osteoarthritis and cartilage
ISSN: 1522-9653
Titre abrégé: Osteoarthritis Cartilage
Pays: England
ID NLM: 9305697

Informations de publication

Date de publication:
05 2022
Historique:
received: 11 12 2020
revised: 17 02 2021
accepted: 06 03 2021
pubmed: 17 3 2021
medline: 27 4 2022
entrez: 16 3 2021
Statut: ppublish

Résumé

Osteoarthritis genetics has been transformed in the past decade through the application of large-scale genome-wide association scans. So far, over 100 polymorphic DNA variants have been associated with this common and complex disease. These genetic risk variants account for over 20% of osteoarthritis heritability and the vast majority map to non-protein coding regions of the genome where they are presumed to act by regulating the expression of target genes. Statistical fine mapping, in silico analyses of genomics data, and laboratory-based functional studies have enabled the identification of some of these targets, which encode proteins with diverse roles, including extracellular signaling molecules, intracellular enzymes, transcription factors, and cytoskeletal proteins. A large number of the risk variants correlate with epigenetic factors, in particular cartilage DNA methylation changes in cis, implying that epigenetics may be a conduit through which genetic effects on gene expression are mediated. Some of the variants also appear to have been selected as humans adapted to bipedalism, suggesting that a proportion of osteoarthritis genetic susceptibility results from antagonistic pleiotropy, with risk variants having a positive role in joint formation but a negative role in the long-term health of the joint. Although data from an osteoarthritis genetic study has not yet directly led to a novel treatment, some of the osteoarthritis associated genes code for proteins that have available therapeutics. Genetic investigations are therefore revealing fascinating fundamental insights into osteoarthritis and can expose options for translational intervention.

Identifiants

pubmed: 33722698
pii: S1063-4584(21)00632-4
doi: 10.1016/j.joca.2021.03.002
pmc: PMC9067452
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

636-649

Subventions

Organisme : Versus Arthritis
ID : 20771
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P020941/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R502182/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : JXR 10641
Pays : United Kingdom

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

Lancet Rheumatol. 2020 Oct;2(10):e633-e645
pubmed: 32989436
Arthritis Rheumatol. 2019 Aug;71(8):1285-1296
pubmed: 30730609
Arthritis Rheumatol. 2021 Jan;73(1):100-109
pubmed: 32755071
Nat Commun. 2021 Jan 20;12(1):467
pubmed: 33473114
Arthritis Rheumatol. 2014 Oct;66(10):2804-15
pubmed: 24980887
Nat Genet. 2017 May;49(5):801-805
pubmed: 28319091
Genetics. 1950 Mar;35(2):212-36
pubmed: 17247344
Pharmacol Res. 2018 Feb;128:73-79
pubmed: 28827187
Hum Mol Genet. 2015 Dec 20;24(25):7432-44
pubmed: 26464490
Osteoarthritis Cartilage. 2019 Oct;27(10):1545-1556
pubmed: 31173883
Nat Rev Rheumatol. 2012 Jan 10;8(2):77-89
pubmed: 22231237
Genetics. 2005 Oct;171(2):813-23
pubmed: 16020784
Ann Rheum Dis. 2011 May;70(5):873-5
pubmed: 20870806
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8218-23
pubmed: 22566624
Nat Genet. 2008 Aug;40(8):994-8
pubmed: 18622395
Hum Mol Genet. 2017 Oct 1;26(19):3850-3858
pubmed: 28934396
PLoS One. 2010 Mar 18;5(3):e9723
pubmed: 20305777
Ann Rheum Dis. 2019 Apr;78(4):446-453
pubmed: 30530827
Ann Rheum Dis. 2018 Apr;77(4):620-623
pubmed: 29436472
Sci Rep. 2018 Oct 19;8(1):15499
pubmed: 30341348
Ann Rheum Dis. 2021 Mar;80(3):376-383
pubmed: 33077471
Biochem Biophys Res Commun. 2020 Sep 10;530(1):252-258
pubmed: 32828295
Arthritis Rheumatol. 2015 May;67(8):2076-84
pubmed: 25939412
Arthritis Rheumatol. 2018 Dec;70(12):1984-1993
pubmed: 29882636
Arthritis Rheumatol. 2018 Oct;70(10):1577-1587
pubmed: 29732726
PLoS Genet. 2019 Apr 25;15(4):e1008060
pubmed: 31022172
Commun Biol. 2018 May 31;1:56
pubmed: 30273415
Ann Rheum Dis. 2015 Oct;74(10):1861-7
pubmed: 24928840
Arthritis Rheumatol. 2017 Feb;69(2):343-351
pubmed: 27696742
Nat Rev Genet. 2018 Aug;19(8):491-504
pubmed: 29844615
J Rheumatol. 2017 Nov;44(11):1652-1658
pubmed: 28916551
Am J Hum Genet. 2011 Sep 9;89(3):446-50
pubmed: 21871595
Science. 2019 Sep 27;365(6460):1409-1413
pubmed: 31604268
Nat Genet. 2018 Dec;50(12):1681-1687
pubmed: 30374069
Curr Opin Rheumatol. 2008 Sep;20(5):553-9
pubmed: 18698177
Arthritis Rheum. 2012 May;64(5):1457-65
pubmed: 22544526
Nat Commun. 2019 Jun 4;10(1):2434
pubmed: 31164647
Ann Rheum Dis. 2018 Mar;77(3):450
pubmed: 29311146
BMC Med Genet. 2014 May 04;15:53
pubmed: 24886551
Nat Genet. 2019 Feb;51(2):230-236
pubmed: 30664745
Ann Rheum Dis. 2017 Dec;76(12):2046-2053
pubmed: 28855172
Lancet. 2012 Sep 1;380(9844):815-23
pubmed: 22763110
Nat Genet. 2018 Apr;50(4):549-558
pubmed: 29559693
Nat Rev Rheumatol. 2011 Sep 27;7(11):654-63
pubmed: 21947178
Bone. 2021 Feb;143:115792
pubmed: 33285254
Genome Biol. 2018 Oct 4;19(1):151
pubmed: 30286773
Ann Rheum Dis. 2014 Dec;73(12):2130-6
pubmed: 23989986
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
Nature. 2017 Oct 11;550(7675):204-213
pubmed: 29022597
Am J Hum Genet. 2018 May 3;102(5):717-730
pubmed: 29727686
Nat Genet. 2014 May;46(5):498-502
pubmed: 24728293
Nat Commun. 2018 May 15;9(1):1911
pubmed: 29765029
Nat Commun. 2015 Jan 19;6:5890
pubmed: 25597830
Arthritis Rheumatol. 2014 Sep;66(9):2450-60
pubmed: 24838673
PLoS One. 2018 Nov 2;13(11):e0202785
pubmed: 30388100
Nucleic Acids Res. 2019 Jan 8;47(D1):D1005-D1012
pubmed: 30445434
Nature. 2013 Sep 26;501(7468):506-11
pubmed: 24037378
Nat Rev Rheumatol. 2020 May;16(5):268-281
pubmed: 32273577
Nat Genet. 2017 Aug;49(8):1202-1210
pubmed: 28671685
J Mol Evol. 2020 Jan;88(1):12-25
pubmed: 31863128
J Orthop Res. 2014 Dec;32(12):1636-45
pubmed: 25212754
Ann Rheum Dis. 2021 Mar;80(3):367-375
pubmed: 33055079
J Physiol. 2019 Mar;597(5):1271-1281
pubmed: 29917242
Nucleic Acids Res. 1996 Jan 1;24(1):238-41
pubmed: 8594589
Osteoarthritis Cartilage. 2020 Nov;28(11):1448-1458
pubmed: 32580029
Arthritis Res Ther. 2019 Jun 18;21(1):149
pubmed: 31215457
Hum Mol Genet. 2018 Oct 1;27(19):3464-3474
pubmed: 30010910
Ann Rheum Dis. 2014 Dec;73(12):2208-12
pubmed: 25261579
Sci Rep. 2017 Aug 21;7(1):8935
pubmed: 28827734
Science. 2012 Sep 7;337(6099):1190-5
pubmed: 22955828
Nat Clin Pract Rheumatol. 2008 Nov;4(11):563
pubmed: 18971933
Arthritis Rheum. 2010 Feb;62(2):499-510
pubmed: 20112360
Nat Genet. 2018 Sep;50(9):1219-1224
pubmed: 30104762
Ann Rheum Dis. 2013 Jul;72(7):1264-5
pubmed: 23505243
PLoS Genet. 2016 Oct 4;12(10):e1006260
pubmed: 27701424
Nat Genet. 2007 Apr;39(4):529-33
pubmed: 17384641
Clin Exp Rheumatol. 2019 Sep-Oct;37 Suppl 120(5):135-140
pubmed: 31621568
Cell. 2020 Apr 16;181(2):362-381.e28
pubmed: 32220312
Nat Rev Genet. 2018 Sep;19(9):581-590
pubmed: 29789686
PLoS Genet. 2010 Apr 01;6(4):e1000888
pubmed: 20369019
Nucleic Acids Res. 2019 Jan 8;47(D1):D1038-D1043
pubmed: 30445645
Trends Pharmacol Sci. 2020 Aug;41(8):557-569
pubmed: 32586653
Ann Rheum Dis. 2014 Apr;73(4):668-77
pubmed: 23505229
PLoS Comput Biol. 2020 Apr 13;16(4):e1007829
pubmed: 32282791
Arthritis Rheumatol. 2015 Nov;67(11):2923-32
pubmed: 26211391
Ann Rheum Dis. 2017 Jul;76(7):1199-1206
pubmed: 27974301
Arthritis Rheumatol. 2019 Apr;71(4):561-570
pubmed: 30298554

Auteurs

G Aubourg (G)

Biosciences Institute, Newcastle University, Newcastle Upon Tyne, UK.

S J Rice (SJ)

Biosciences Institute, Newcastle University, Newcastle Upon Tyne, UK.

P Bruce-Wootton (P)

Biosciences Institute, Newcastle University, Newcastle Upon Tyne, UK.

J Loughlin (J)

Biosciences Institute, Newcastle University, Newcastle Upon Tyne, UK. Electronic address: john.loughlin@newcastle.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH